809 related articles for article (PubMed ID: 19308042)
1. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
2. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
[TBL] [Abstract][Full Text] [Related]
3. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
[TBL] [Abstract][Full Text] [Related]
5. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
6. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
[TBL] [Abstract][Full Text] [Related]
7. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
11. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
[TBL] [Abstract][Full Text] [Related]
13. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
14. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
[TBL] [Abstract][Full Text] [Related]
15. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
[TBL] [Abstract][Full Text] [Related]
16. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
[TBL] [Abstract][Full Text] [Related]
18. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
